Findings suggest that urinary ceramide levels could serve as an early biomarker for acute kidney injury, helping doctors identify patients at risk.
Niagen Bioscience, Inc. , the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today shared promising results from the first-of-its-kind ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback